NeoGenomics, Inc.
(NASDAQ : NEO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Services » Medical Or Nursing Services
symbolcompany%chnglast%shortavg$volume
NVTAInvitae Corp. 2.96%50.811.4%$137.23m
GHGuardant Health, Inc. 1.56%121.510.0%$129.21m
DVADaVita, Inc. -3.50%104.573.5%$93.96m
SDCSmileDirectClub, Inc. -3.27%11.550.0%$85.57m
FLGTFulgent Genetics, Inc. -9.83%42.450.7%$72.77m
ONEM1Life Healthcare, Inc. 3.04%35.880.0%$71.64m
NTRANatera, Inc. -2.32%88.661.2%$55.85m
MDMEDNAX, Inc. 0.81%21.1911.1%$46.82m
CHEChemed Corp. -0.52%474.2210.1%$42.94m
AMEDAmedisys, Inc. -0.47%246.2711.3%$38.11m
LHCGLHC Group, Inc. 0.48%197.082.9%$37.19m
NEONeoGenomics, Inc. 1.56%47.995.7%$29.13m
OTRKOntrak, Inc. 0.06%51.360.0%$23.89m
ACHCAcadia Healthcare Co., Inc. -0.85%41.9227.1%$23.13m
CRDFCardiff Oncology, Inc. -8.07%20.520.0%$17.91m

Company Profile

NeoGenomics, Inc. is a clinical laboratory company, which specializes in cancer genetics diagnostic testing and pharma services. It operates through the Clinical Services and Pharma Services segments. The Clinical Services segment offers cancer testing services to community-based pathologists, hospitals, academic centers, and oncology groups. The Pharma Services segment focuses on supporting pharmaceutical firms in drug development programs by supporting various clinical trials. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.